InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Nofi Michael, Directeur Comptable. Director active across 2 companies, notably SpringWorks Therapeutics, Inc.. Cumulatively, 9 disclosures have been logged. Activity tracked since 7 January 2022. The latest transaction was filed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nofi Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
30,623 股Common StockSEC:0001104659-25-065302:0
6,929 股0Common StockSEC:0001104659-25-003466:0
2,388 股@ US$38.1945.2% 占其流量Common StockSEC:0001104659-25-001773:0
14,104 股0Common StockSEC:0001104659-24-002376:0
409 股@ US$26.415.2% 占其流量Common StockSEC:0001104659-23-002719:0
9,713 股Common StockSEC:0001104659-23-002314:0
414 股@ US$56.0613.9% 占其流量Common StockSEC:0001104659-22-004467:0
567 股@ US$56.0619.0% 占其流量Common StockSEC:0001104659-22-003145:0
5,748 股Common StockSEC:0001104659-22-002739:0
9 条申报中的 9 条
About Nofi Michael
Nofi Michael is Directeur Comptable and Chief Accounting Officer at SpringWorks Therapeutics, Inc. The record contains 9 filings in total, and the sampled filings cover the period from January 10, 2022 to July 2, 2025, with the transaction nature mainly listed as Attribution.
